Ann Arbor, MI, United States of America

Sooryanarayana Lnu

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Michigan. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sooryanarayana Lnu. Retrieved from https://idiyas.com/inventor/sooryanarayana-lnu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Therapy by Sooryanarayana Lnu

Introduction

Sooryanarayana Lnu is an accomplished inventor based in Ann Arbor, MI. He has made significant contributions to the field of cancer research, particularly in developing therapeutic targets for prostate cancer. His work focuses on innovative methods to inhibit EZH2, a protein implicated in cancer progression.

Latest Patents

Sooryanarayana Lnu holds a patent titled "Compositions and methods for inhibiting EZH2." This invention relates to small molecules and nucleic acids that target EZH2 expression in prostate cancer. His patent represents a promising advancement in cancer therapy, offering new avenues for treatment.

Career Highlights

Lnu is affiliated with the University of Michigan, where he conducts his research. His work has garnered attention for its potential impact on cancer treatment strategies. With a focus on innovative solutions, he continues to explore the complexities of cancer biology.

Collaborations

Sooryanarayana Lnu collaborates with notable researchers, including Arul M Chinnaiyan and Qi Cao. These partnerships enhance the scope and depth of his research, contributing to the advancement of cancer therapies.

Conclusion

Sooryanarayana Lnu's innovative work in cancer research exemplifies the potential of targeted therapies in treating prostate cancer. His contributions are paving the way for future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…